Table IV.
Follow-up time | Treatment with UVB phototherapy | Number of UVB phototherapy treatments | ||||
---|---|---|---|---|---|---|
HR | 95% CI | p-value | HR | 95% CI | p-value | |
3 years | 0.832 | 0.319–2.172 | 0.71 | 1.004 | 0.984–1.025 | 0.68 |
6 years | 0.844 | 0.376–1.894 | 0.68 | 1.003 | 0.982–1.023 | 0.81 |
9 years | 1.074 | 0.557–2.071 | 0.83 | 1.003 | 0.987–1.018 | 0.74 |
12 years | 1.129 | 0.616–2.068 | 0.70 | 1.002 | 0.986–1.018 | 0.82 |
15 years | 1.068 | 0.585–1.950 | 0.83 | 1.001 | 0.984–1.018 | 0.89 |
Multivariate Cox proportional hazards models adjusted for the exposure variable of UVB phototherapy, age, sex, occupation, high Uv index, organ transplantation, and the prescription of hydrochlorothiazide at different follow-up times.
CI: confidence interval; HR: hazard ratio.